Cholesterol modulates the interaction of β-amyloid peptide with lipid bilayers

Biophysical Journal

Volumn 96, Issue 10, 2009, Pages 4299-4307

  Qiu, Liming ^a   Lewis, Anthony ^a   Como, John ^a   Vaughn, Mark W ^b   Huang, Juyang ^a   Somerharju, Pentti ^c   Virtanen, Jorma ^d   Kwan, Hon Cheng ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b Department of Electrical and Computer Engineering   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CHOLESTEROL; ERGOSTEROL; MONOMER; OLIGOMER; STEROL; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; DEHYDROERGOSTEROL; DRUG DERIVATIVE; PEPTIDE FRAGMENT; TYROSINE;

ANISOTROPY; ARTICLE; COMPLEX FORMATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; LIPID BILAYER; NERVE CELL MEMBRANE; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN INTERACTION; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CHEMISTRY; FLUORESCENCE POLARIZATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN BINDING; TIME;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; CHOLESTEROL; ERGOSTEROL; FLUORESCENCE POLARIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIPID BILAYERS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; TIME FACTORS; TYROSINE;

EID: 68049131387     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.02.036     Document Type: Article

References (37)

1. Roberson, E. D., and L. Mucke. 2006. 100 years and counting: prospects for defeating Alzheimer's disease. Science. 314:781-784.
2. Selkoe, D. J. 1991. The molecular pathology of Alzheimer's disease. Neuron. 6:487-498.
3. Bokvist, M., F. Lindstrom, A. Watts, and G. Grobner. 2004. Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335:1039-1049.
4. Ji, S. R., Y. Wu, and S. F. Sui. 2002. Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (A β 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277:6273-6279.
5. Terzi, E., G. Holzemann, and J. Seelig. 1995. Self-association of β-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252:633-642.
6. Luhrs, T., C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, et al. 2005. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 102:17342-17347.
7. Hardy, J. A., and G. A. Higgins. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:184-185.
8. Nelson, T. J., and D. L. Alkon. 2005. Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide. J. Biol. Chem. 280:7377-7387.
9. Lin, H., R. Bhatia, and R. Lal. 2001. Amyloid b protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15:2433-2444.
10. Cheng, K. H., B. Cannon, J. Metze, A. Lewis, J. Huang, et al. 2006. Lipid headgroup superlattice modulates the activity of surface-acting cholesterol oxidase in ternary phospholipid/cholesterol bilayers. Biochemistry. 45:10855-10864.
11. Chong, P. L. 1994. Evidence for regular distribution of sterols in liquid crystalline phosphatidylcholine bilayers. Proc. Natl. Acad. Sci. USA. 91:10069-10073.
12. Somerharju, P., J. A. Virtanen, and K. H. Cheng. 1999. Lateral organisation of membrane lipids. The superlattice view. Biochim. Biophys. Acta. 1440:32-48.
13. Simons, K., and W. L. Vaz. 2004. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33:269-295.
14. Kingsley, P. B., and G. W. Feigenson. 1979. The synthesis of a perdeuterated phospholipid: 1,2-dimyristoyl-sn-glycero-3-phosphocholine- d72. Chem. Phys. Lipids. 24:135-147.
15. Kremer, J. J., M. M. Pallitto, D. J. Sklansky, and R. M. Murphy. 2000. Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry. 39:10309-10318.
16. Kremer, J. J., D. J. Sklansky, and R. M. Murphy. 2001. Profile of changes in lipid bilayer structure caused by β-amyloid peptide. Biochemistry. 40:8563-8571.
17. Arispe, N., and M. Doh. 2002. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides. FASEB J. 16:1526-1536.
18. Curtain, C. C., F. E. Ali, D. G. Smith, A. I. Bush, C. L. Masters, et al. 2003. Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-b peptide with membrane lipid. J. Biol. Chem. 278:2977-2982.
19. Buboltz, J. T., and G. W. Feigenson. 1999. A novel strategy for the preparation of liposomes: rapid solvent exchange. Biochim. Biophys. Acta. 1417:232-245.
20. Cannon, B., N. Weaver, Q. Pu, V. Thiagarajan, S. Liu, et al. 2005. Cholesterol modulated antibody binding in supported lipid membranes as determined by total internal reflectance microscopy on a microfabricated high-throughput glass chip. Langmuir. 21:9666-9674.
21. Cannon, B., A. Lewis, J. Metze, V. Thiagarajan, M. W. Vaughn, et al. 2006. Cholesterol supports headgroup superlattice domain formation in fluid phospholipid/cholesterol bilayers. J. Phys. Chem. B. 110:6339-6350.
22. Ali, M. R., K. H. Cheng, and J. Huang. 2007. Assess the nature of cholesterol-lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayers. Proc. Natl. Acad. Sci. USA. 104:5372-5377.
23. Waschuk, S. A., E. A. Elton, A. A. Darabie, P. E. Fraser, and J. A. McLaurin. 2001. Cellular membrane composition defines A β-lipid interactions. J. Biol. Chem. 276:33561-33568.
24. Gratton, E., D. M. Jameson, and R. D. Hall. 1984. Multifrequency phase and modulation fluorometry. Annu. Rev. Biophys. Bioeng. 13:105-124.
25. Cheng, K. H., J. Virtanen, and P. Somerharju. 1999. Fluorescence studies of dehydroergosterol in phosphatidylethanolamine/phosphatidylcholine bilayers. Biophys. J. 77:3108-3119.
26. Spencer, R. D., and G. Weber. 1970. Influence of Brownian rotation and energy transfer upon the measurements of fluorescence lifetime. J. Chem. Phys. 52:1654-1663.
27. Perrin, F. 1936. Mouvement Brownien d'un ellipsoide. II. Rotation libre et dipolarisation des florescences. Transaction et diffusion de molecules ellipsoidoles. J. Phys. Radium. 71:1-44.
28. Schroeder, F., Y. Barenholz, E. Gratton, and T. E. Thompson. 1987. A fluorescence study of dehydroergosterol in phosphatidylcholine bilayer vesicles. Biochemistry. 26:2441-2448.
29. Wu, P., and L. Brand. 1992. Orientation factor in steady-state and time-resolved resonance energy transfer measurements. Biochemistry. 31:7939-7947.
30. Cheng, K. H., T. Wiedmer, and P. J. Sims. 1985. Fluorescence resonance energy transfer study of the associative state of membrane-bound complexes of complement proteins C5b-8. J. Immunol. 135:459-464.
31. Cannon, B., G. Heath, J. Huang, P. Somerharju, J. A. Virtanen, et al. 2003. Time-resolved fluorescence and fourier transform infrared spectroscopic investigations of lateral packing defects and superlattice domains in compositionally uniform cholesterol/phosphatidylcholine bilayers. Biophys. J. 84:3777-3791.
32. Ferguson, G. A. 1971. Statistical Analysis in Psychology and Education. McGraw-Hill, New York.
33. Liu, F., I. P. Sugar, and P. L. Chong. 1997. Cholesterol and ergosterol superlattices in three-component liquid crystalline lipid bilayers as revealed by dehydroergosterol fluorescence. Biophys. J. 72:2243-2254.
34. Wang, M. M., M. Olsher, I. P. Sugar, and P. L. Chong. 2004. Cholesterol superlattice modulates the activity of cholesterol oxidase in lipid membranes. Biochemistry. 43:2159-2166.
35. Liu, F., and P. L. Chong. 1999. Evidence for a regulatory role of cholesterol superlattices in the hydrolytic activity of secretory phospholipase A2 in lipid membranes. Biochemistry. 38:3867-3873.
36. Venegas, B., I. P. Sugar, and P. L. Chong. 2007. Critical factors for detection of biphasic changes in membrane properties at specific sterol mole fractions for maximal superlattice formation. J. Phys. Chem. B. 111:5180-5192.
37. Stepaniants, S., S. Izrailev, and K. Schulten. 1997. Extraction of lipids from phospholipid membranes by steered molecular dynamics. J. Mol. Model. 3:473-475.